Can urodynamics distinguish between urethral strictures and Benign Prostatic Hyperplasia (BPH)?

Abstract

Objectives:

We tested whether pressure flow studies could distinguish between patients with Benign Prostatic Hyperplasia (BPH) and urethral strictures and hypothesised that urethral strictures were associated with a lower closure pressure and increased slope of the passive urethral relation compared to benign prostatic obstruction.

Patients and method:

Ninety patients who had Transurethral Resection of Prostate (TURP) and 45 male patients who had an optical urethrotomy or urethral dilatation for urethral stricture disease, who had a prior urodynamics study, were evaluated.

Results:

Patients with urethral stricture disease had lower closure pressures than those undergoing TURP (22.07 vs. 28.4 cmH₂O, p=0.0039, r=0.61). However, the slope of the passive urethral relation was indistinguishable between the two groups. Only 60% of patients with symptomatic urethral strictures were categorised as unequivocally obstructed by the Abrams-Griffiths nomogram.

Conclusion:

Urethral strictures are associated with lower closure pressures than prostatic obstruction; however, there was no difference in the urethral resistance relation.

Keywords

Urodynamics Benign Prostatic Hyperplasia (BPH)strictures Transurethral Resection of Prostate (TURP)urethrotomy dilatation

Get full access to this article

View all access options for this article.

References

Schafer

. Analysis of bladder-outlet function with the linearized passive urethral resistance relation, linPURR, and a disease-specific approach for grading obstruction: from complex to simple. World J Urol 1995; 13: 47–58.

Spangberg

. Estimation of urethral resistance by curve fitting in the pressure-flow plot. Theory and experience in normal men and men with benign prostatic hypertrophy. World J Urol 1995; 13: 65–69.

Abrams

. Bladder outlet obstruction index, bladder contractility index and bladder voiding efficiency: three simple indices to define bladder voiding function. BJU Int 1999; 84: 14–15.

Anger

Santucci

Grossberg

. The morbidity of urethral stricture disease among male medicare beneficiaries. BMC Urol 2010; 10: 3.

Santucci

Joyce

Wise

. Male urethral stricture disease. J Urol 2007; 177: 1667–1674.

Zehri

Ather

Afshan

. Predictors of recurrence of urethral stricture disease following optical urethrotomy. Int J Surg 2009; 7: 361–364.

Greenwell

Castle

Andrich

. Repeat urethrotomy and dilation for the treatment of urethral stricture are neither clinically effective nor cost-effective. J Urol 2004; 172: 275–277.

Benchekroun

Lachkar

Soumana

. Internal urethrotomy in the treatment of urethral stenoses (longterm results)]. Ann Urol (Paris) 1998; 32: 99–102.

Johnston

Bagshaw

Flynn

. Visual internal urethrotomy. Br J Urol 1980; 52: 542–545.

10.

Ruutu

Alfthan

Standertskjold-Nordenstam

. Treatment of urethral stricture by urethroplasty or direct vision urethrotomy. A comparative retrospective study. Scand J Urol Nephrol 1983; 17: 1–4.

11.

Yamanishi

Yasuda

Kamai

. Single-blind, randomized controlled study of the clinical and urodynamic effects of an alpha-blocker (naftopidil) and phytotherapy (eviprostat) in the treatment of benign prostatic hyperplasia. Int J Urol 2004; 11: 501–509.

12.

Schafer

. Principles and clinical application of advanced urodynamic analysis of voiding function. Urol Clin North Am 1990; 17: 553–566.

13.

Swets

. Measuring the accuracy of diagnostic systems. Science 1988; 240: 1285–1293.

14.

Idriz

Bishara

Kirkham

. The comparative pressure-flow plot properties of radiological bladder neck and prostatic obstruction. BJU Int 2009; 104: 1670–1675.

15.

Griffiths

. The mechanics of the urethra and of micturition. Br J Urol 1973; 45: 497–507.

16.

Abrams

Farrar

Turner-Warwick

. The results of prostatectomy: a symptomatic and urodynamic analysis of 152 patients. J Urol 1979; 121: 640–642.

17.

Seki

Takei

Yamaguchi

. Analysis of prognostic factors regarding the outcome after a transurethral resection for symptomatic benign prostatic enlargement. Neurourol Urodyn 2006; 25: 428–432.